These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21458579)

  • 1. Amyloid in neurodegenerative diseases: friend or foe?
    Wolfe KJ; Cyr DM
    Semin Cell Dev Biol; 2011 Jul; 22(5):476-81. PubMed ID: 21458579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular chaperones antagonize proteotoxicity by differentially modulating protein aggregation pathways.
    Douglas PM; Summers DW; Cyr DM
    Prion; 2009; 3(2):51-8. PubMed ID: 19421006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amyloid deposits: protection against toxic protein species?
    Treusch S; Cyr DM; Lindquist S
    Cell Cycle; 2009 Jun; 8(11):1668-74. PubMed ID: 19411847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?
    Muchowski PJ
    Neuron; 2002 Jul; 35(1):9-12. PubMed ID: 12123602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Process, Outcomes and Possible Elimination of Aggregation with Special Reference to Heme Proteins; Likely Remediations of Proteinopathies.
    Furkan M; Khan RH
    Curr Protein Pept Sci; 2020; 21(6):573-583. PubMed ID: 32013844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation.
    Nerelius C; Fitzen M; Johansson J
    Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein misfolding in neurodegenerative diseases.
    Agorogiannis EI; Agorogiannis GI; Papadimitriou A; Hadjigeorgiou GM
    Neuropathol Appl Neurobiol; 2004 Jun; 30(3):215-24. PubMed ID: 15175075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
    Hervás R; Oroz J
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defining the limits: Protein aggregation and toxicity in vivo.
    Holmes WM; Klaips CL; Serio TR
    Crit Rev Biochem Mol Biol; 2014; 49(4):294-303. PubMed ID: 24766537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chaperone-dependent amyloid assembly protects cells from prion toxicity.
    Douglas PM; Treusch S; Ren HY; Halfmann R; Duennwald ML; Lindquist S; Cyr DM
    Proc Natl Acad Sci U S A; 2008 May; 105(20):7206-11. PubMed ID: 18480252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapeutic potential of chemical chaperones in protein folding diseases.
    Cortez L; Sim V
    Prion; 2014; 8(2):197-202. PubMed ID: 24818993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Chaperones in Neurodegenerative Diseases: A Short Review.
    Bobori C; Theocharopoulou G; Vlamos P
    Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clusterin and Alzheimer's disease.
    Calero M; Rostagno A; Frangione B; Ghiso J
    Subcell Biochem; 2005; 38():273-98. PubMed ID: 15709484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collective roles of molecular chaperones in protein degradation pathways associated with neurodegenerative diseases.
    Luo GR; Le WD
    Curr Pharm Biotechnol; 2010 Feb; 11(2):180-7. PubMed ID: 20166963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Amyloid States by Molecular Chaperones.
    Wentink A; Nussbaum-Krammer C; Bukau B
    Cold Spring Harb Perspect Biol; 2019 Jul; 11(7):. PubMed ID: 30755450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein folding and misfolding in the neurodegenerative disorders: a review.
    Bolshette NB; Thakur KK; Bidkar AP; Trandafir C; Kumar P; Gogoi R
    Rev Neurol (Paris); 2014 Mar; 170(3):151-61. PubMed ID: 24613386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein interaction networks in neurodegenerative diseases: From physiological function to aggregation.
    Calabrese G; Molzahn C; Mayor T
    J Biol Chem; 2022 Jul; 298(7):102062. PubMed ID: 35623389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Protein Scaffolding Functions of Polyphosphate.
    Guan J; Jakob U
    J Mol Biol; 2024 Jul; 436(14):168504. PubMed ID: 38423453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.